Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOCO
3451
DELISTED
GoHealth
GOCO
| $87.2K | ﹤0.01% |
4,426
-4,675
| -51% | -$73.4K |
|
3452
Lifecore Biomedical
LFCR
$166M
| $86.7K | ﹤0.01% |
8,965
+8,917
| +18,577% | +$54.5K |
|
3453
Pampa Energía
PAM
$4.75B
| $86.6K | ﹤0.01% |
+2,000
| New | +$74.1K |
|
3454
Lexicon Pharmaceuticals
LXRX
$1.03B
| $86.3K | ﹤0.01% |
37,669
-4,627
| -11% | -$12.3K |
|
3455
Lands' End
LE
$370M
| $86.2K | ﹤0.01% |
11,104
+3,299
| +42% | +$26.6K |
|
3456
Defiance Quantum ETF
QTUM
$5.23B
| $86K | ﹤0.01% |
1,700
| – | – |
|
|
TGB
3457
Trekor Metals
TGB
$2.48B
| $86K | ﹤0.01% |
60,117
+54,517
| +974% | +$81.6K |
|
|
SRDX
3458
DELISTED
Surmodics
SRDX
| $85.8K | ﹤0.01% |
2,739
-4,157
| -60% | -$94.9K |
|
3459
Valaris Ltd Warrants
VAL.WS
$684M
| $85.6K | ﹤0.01% |
8,116
| – | – |
|
3460
Universal Logistics Holdings
ULH
$353M
| $85.6K | ﹤0.01% |
2,971
-651
| -18% | -$18K |
|
3461
Magnachip Semiconductor
MX
$119M
| $85.6K | ﹤0.01% |
+7,654
| New | +$74.8K |
|
3462
iShares MSCI Indonesia ETF
EIDO
$480M
| $85.3K | ﹤0.01% |
3,700
| – | – |
|
3463
Avita Medical
RCEL
$135M
| $85.2K | ﹤0.01% |
+5,008
| New | +$73.5K |
|
|
CUK
3464
DELISTED
Carnival PLC
CUK
| $84.8K | ﹤0.01% |
5,000
| – | – |
|
3465
Personalis
PSNL
$1.35B
| $84.6K | ﹤0.01% |
45,024
-30,509
| -40% | -$69K |
|
|
HDSN
3466
Hudson Technologies
HDSN
$254M
| $84.1K | ﹤0.01% |
8,740
-13,076
| -60% | -$114K |
|
3467
Ares Capital
ARCC
$13.5B
| $84K | ﹤0.01% |
4,470
-8,495
| -66% | -$157K |
|
3468
Brookfield Asset Management
BAM
$77.3B
| $83.9K | ﹤0.01% |
2,570
-14,419
| -85% | -$464K |
|
3469
Caesarstone
CSTE
$72.3M
| $83.5K | ﹤0.01% |
15,931
-10,428
| -40% | -$47.2K |
|
|
SNPO
3470
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $83.4K | ﹤0.01% |
7,158
-1,976
| -22% | -$18.5K |
|
3471
Digimarc Corp
DMRC
$147M
| $83.4K | ﹤0.01% |
2,832
-4,098
| -59% | -$101K |
|
|
FAZ
3472
DELISTED
Direxion Daily Financial Bear 3x ETF
FAZ
| $83.3K | ﹤0.01% |
440
| – | – |
|
3473
OneWater Marine
ONEW
$204M
| $83.3K | ﹤0.01% |
2,298
-3,517
| -60% | -$104K |
|
3474
Invesco NASDAQ Internet ETF
PNQI
$528M
| $82.7K | ﹤0.01% |
2,645
| – | – |
|
3475
Immuneering
IMRX
$267M
| $82.6K | ﹤0.01% |
8,144
+2,927
| +56% | +$28.1K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.